Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Intercept Pharmaceuticals (ICPT) stocks in Canada

Learn how to easily invest in Intercept Pharmaceuticals stocks.

Intercept Pharmaceuticals is a biotechnology business based in the US. Intercept Pharmaceuticals stocks (ICPT.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $18.85 – a decrease of 13.23% over the previous week. Intercept Pharmaceuticals employs 498 staff and has a trailing 12-month revenue of around $354.3 million.

How to buy shares in Intercept Pharmaceuticals

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ICPT – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Intercept Pharmaceuticals stock price (NASDAQ:ICPT)

Use our graph to track the performance of ICPT stocks over time.

Intercept Pharmaceuticals shares at a glance

Information last updated 2022-01-18.
Latest market close$15.41
52-week range$11.60 - $38.94
50-day moving average $16.89
200-day moving average $17.45
Wall St. target price$30.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-3.28

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
Wealthsimple Trade
Finder Rating:
3.9 / 5
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
3.8 / 5
$4.99 - $9.99
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
4.1 / 5
Min. $1.00, Max. 0.5%
Stocks, Bonds, Options, ETFs, Currencies, Futures
CIBC Investor's Edge
Finder Rating:
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Finder Rating:
4.2 / 5
$4.95 - $9.95
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get a $50 bonus when you open a new RRSP, TFSA or RESP and start pre-authorized contributions of $200+/month. Valid until March 1, 2022.

Compare up to 4 providers

Online stock trading

Is it a good time to buy Intercept Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Intercept Pharmaceuticals price performance over time

Historical closes compared with the close of $15.41 from 2022-01-21

1 week (2022-01-14) -13.23%
1 month (2021-12-23) -13.77%
3 months (2021-10-22) -10.04%
6 months (2021-07-23) -8.82%
1 year (2021-01-22) -47.69%
2 years (2020-01-24) -84.06%
3 years (2019-01-24) 116.45
5 years (2017-01-24) 105.4

Intercept Pharmaceuticals financials

Revenue TTM $354.3 million
Gross profit TTM $307.4 million
Return on assets TTM -8.33%
Return on equity TTM -143254.91%
Profit margin -30.28%
Book value $1.57
Market capitalisation $524.8 million

TTM: trailing 12 months

Intercept Pharmaceuticals share dividends

We're not expecting Intercept Pharmaceuticals to pay a dividend over the next 12 months.

Intercept Pharmaceuticals share price volatility

Over the last 12 months, Intercept Pharmaceuticals's shares have ranged in value from as little as $11.6 up to $38.94. A popular way to gauge a stock's volatility is its "beta".

ICPT.US volatility(beta: 1.41)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Intercept Pharmaceuticals's is 1.4075. This would suggest that Intercept Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Intercept Pharmaceuticals overview

Intercept Pharmaceuticals, Inc. , a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. Its lead products candidate is the Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid in adults. The company is also developing Ocaliva for various indications, including nonalcoholic steatohepatitis (NASH); and other product candidates in various stages of clinical and preclinical development. It has a license agreement with Aralez Pharmaceuticals Canada Inc. to develop and commercialize bezafibrate in the United States. The company markets its products through an internal commercial organization, a contract sales organization, and third-party distributors.

Stocks similar to Intercept Pharmaceuticals

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Ask an Expert

You must be logged in to post a comment.

Go to site